MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.010
-0.060 (-5.61%)
At close: Nov 20, 2026, 4:00 PM EST
1.050
+0.040 (3.96%)
After-hours: Nov 20, 2026, 7:26 PM EST
MetaVia Market Cap
MetaVia has a market cap or net worth of $6.81 million as of November 20, 2026. It is the 43,162nd most valuable company in the world and the 5,686th biggest in the United States. Its market cap has decreased by 63.19% in one year.
Market Cap
6.81M
Enterprise Value
-1.81M
1-Year Change
-63.19%
Global Rank
Country Rank
#5,686 United States
Category
ChartMarket Cap Chart
Since December 31, 2019, MetaVia's market cap has decreased from $104.41B to $6.81M, a decrease of -99.99%. That is a compound annual growth rate of -75.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 6.81M | -63.26% |
| Dec 31, 2025 | 18.54M | 5.97% |
| Dec 31, 2024 | 17.49M | -2.47% |
| Dec 29, 2023 | 17.93M | 31.75% |
| Dec 30, 2022 | 13.61M | -58.04% |
| Dec 31, 2021 | 32.44M | -62.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aligos Therapeutics | 7.62M |
| Moleculin Biotech | 7.54M |
| Vistagen Therapeutics | 7.26M |
| Ensysce Biosciences | 7.00M |
| Addex Therapeutics | 6.38M |
| Kyntra Bio | 6.32M |
| Acurx Pharmaceuticals | 6.30M |
| AEON Biopharma | 6.14M |